RMSC 2015 第八屆再生醫(yī)學(xué)與干細(xì)胞大會(huì)通知
RMSC 2015 第八屆再生醫(yī)學(xué)與干細(xì)胞大會(huì)
主題：點(diǎn)燃“不治之癥”的希望之火
2015年3月19-21日 | 韓國(guó) 釜山國(guó)際會(huì)展中心
由百奧泰國(guó)際會(huì)議（大連）有限公司主辦，國(guó)際組織工程與再生醫(yī)學(xué)協(xié)會(huì)、韓國(guó)首爾大學(xué)融合技術(shù)院聯(lián)合支持的第八屆再生醫(yī)學(xué)與干細(xì)胞大會(huì)將于2015年3月19-21日在韓國(guó)釜山國(guó)際會(huì)展中心舉行，本屆會(huì)議的主題是：點(diǎn)燃“不治之癥”的希望之火。
再生醫(yī)學(xué)與干細(xì)胞構(gòu)成了一個(gè)巨大的醫(yī)療技術(shù)和服務(wù)行業(yè),這個(gè)領(lǐng)域包含了多學(xué)科交流與合作,如基礎(chǔ)科學(xué)、新興技術(shù)和臨床轉(zhuǎn)化。在21世紀(jì)高科技領(lǐng)域中，巨大潛力的再生醫(yī)學(xué)生物技術(shù)產(chǎn)業(yè)鏈將成為核心。進(jìn)入第八個(gè)年頭，國(guó)際再生醫(yī)學(xué)與干細(xì)胞大會(huì)在不斷成長(zhǎng)，RMSC-2015（韓國(guó)）將為參與者提供對(duì)研究,戰(zhàn)略業(yè)務(wù)規(guī)劃,決策和未來(lái)的職業(yè)發(fā)展有用的資源、信息和建議。
再生醫(yī)學(xué)和干細(xì)胞大會(huì)已經(jīng)成功舉辦過(guò)七屆，本次會(huì)議包含：全球干細(xì)胞經(jīng)濟(jì)，市場(chǎng)，政策，法規(guī)和倫理問(wèn)題、干細(xì)胞前沿科學(xué)、干細(xì)胞技術(shù)、干細(xì)胞和再生醫(yī)學(xué)、干細(xì)胞組織工程、干細(xì)胞藥物開(kāi)發(fā)和發(fā)展、干細(xì)胞產(chǎn)品再生醫(yī)學(xué)資金和投資等七個(gè)研討專題，涵蓋36個(gè)研討方向。
我們真誠(chéng)地希望您參加本次會(huì)議，在2015年3月與新朋舊友共聚韓國(guó)釜山，和大師同行，與精英為伍。通過(guò)面對(duì)面的交流，您將找到新的合作伙伴，發(fā)現(xiàn)新的思路，促進(jìn)國(guó)際合作與交流。（目前，部分科技論壇仍有演講機(jī)會(huì)，大會(huì)征集英文論文摘要、英文演講、英文項(xiàng)目海報(bào)、企業(yè)展位，歡迎精英參會(huì)并誠(chéng)邀贊助單位�。�
2015第八屆再生醫(yī)學(xué)與干細(xì)胞大會(huì)會(huì)務(wù)組
聯(lián)系人：Vicki Qian
電話：0411-84799609-801；18504200209
Q Q: 1950231799(請(qǐng)注明咨詢會(huì)議)
電子郵件：vicki@
地址：大連市高新園區(qū)匯賢園1號(hào) 郵編：116025
大會(huì)網(wǎng)站：http://www.bitcongress.com/RMSC-Korea2015/cn/default.asp
會(huì)議報(bào)名：http://www.bitcongress.com/RMSC-Korea2015/cn/zhuce.asp
大會(huì)議題（會(huì)議語(yǔ)言為全英文，無(wú)同聲傳譯）：
Tentative Program Layout
Stream 1: Main Conference
Part 1: Opening Ceremony
Part 2: Keynote Forum of RMSC 2015-Korea
Part 3: Global Stem Cell Economy, Market, Policy, Strategy, Legal and Ethic Issues
Session P 3-1: The Development Trend of Global Stem Cell Economy and Market
Session P 3-2: Ethic, Safety Issues and Social Acceptance of Stem Cell Research
Session P 3-3: Global Stem Cell Policy, Strategy and Legal Issues
Part 1: Opening Ceremony
Part 2: Keynote Forum of RMSC 2015-Korea
Part 3: Global Stem Cell Economy, Market, Policy, Strategy, Legal and Ethic Issues
Session P 3-1: The Development Trend of Global Stem Cell Economy and Market
Session P 3-2: Ethic, Safety Issues and Social Acceptance of Stem Cell Research
Session P 3-3: Global Stem Cell Policy, Strategy and Legal Issues
Stream 2: Thematic Scientific Program
Module 1: Frontier Science of Stem Cell
Session 101: Genomics and Epigenomics of Stem Cells
Session 102: Systems Biology of Stem Cells
Session 103: Mitochondrial DNA, Mitochondrial Diseases and Stem Cell
Session 104: Cell Cycle Control, Checkpoint and Stem Cell Biology
Session 105: Stem Cell Lineage, Derivation and Differentiation
Session 106: Nuclear Cloning and Epigenetic Reprogramming
Session 107: Reproductive and Developmental Biology
Session 108: Neural Stem Cells and Development
Session 109: Cancer Stem Cells
Session 110: Stem Cells and Gene Therapy
Module 1: Frontier Science of Stem Cell
Session 101: Genomics and Epigenomics of Stem Cells
Session 102: Systems Biology of Stem Cells
Session 103: Mitochondrial DNA, Mitochondrial Diseases and Stem Cell
Session 104: Cell Cycle Control, Checkpoint and Stem Cell Biology
Session 105: Stem Cell Lineage, Derivation and Differentiation
Session 106: Nuclear Cloning and Epigenetic Reprogramming
Session 107: Reproductive and Developmental Biology
Session 108: Neural Stem Cells and Development
Session 109: Cancer Stem Cells
Session 110: Stem Cells and Gene Therapy
Session 111: Embryonic-like Stem Cells and Primo Vascular System
Module 2: Stem Cells Technologies
Session 201: Cell Based Technologies
Session 202: Stem Cell Banking
Session 203: Stem Cell Sourcing, Preservation and Cryopreservation
Session 204: Imaging, Modeling and Monitoring Technologies
Session 205: Stem Cell Extraction, Expansion, and Stage Stem Cell Products
Session 201: Cell Based Technologies
Session 202: Stem Cell Banking
Session 203: Stem Cell Sourcing, Preservation and Cryopreservation
Session 204: Imaging, Modeling and Monitoring Technologies
Session 205: Stem Cell Extraction, Expansion, and Stage Stem Cell Products
Module 3: Stem Cell and Regenerative Medicine
Session 301: Neural Degenerative Diseases, Stroke and CNS Repairing
Session 302: Bone, Cartilage, Artificial Ligaments and Tendon Tissue Repairing
Session 303: Stem Cell in Eye Disease and Plastic Surgery
Session 304: Cardiovascular, Cardiac Tissue Regeneration or Repair and Vascular Disease
Session 305: Hematopoietic Stem Cell Transplantation and Bone Marrow Transplantation
Session 306: Stem Cell Therapy for Autoimmune Diseases
Session 307: Digestive Respiratory and Urologic Tissues and Organ Regeneration
Session 301: Neural Degenerative Diseases, Stroke and CNS Repairing
Session 302: Bone, Cartilage, Artificial Ligaments and Tendon Tissue Repairing
Session 303: Stem Cell in Eye Disease and Plastic Surgery
Session 304: Cardiovascular, Cardiac Tissue Regeneration or Repair and Vascular Disease
Session 305: Hematopoietic Stem Cell Transplantation and Bone Marrow Transplantation
Session 306: Stem Cell Therapy for Autoimmune Diseases
Session 307: Digestive Respiratory and Urologic Tissues and Organ Regeneration
Module 4: Stem Cell Tissues Engineering
Session 401: Biomechanics Stem Cell and Tissue
Session 402: Computer-Aided Tissue Engineering
Session 403: Biofabrication and Tissue Engineering
Session 404: Cell Culture, Bioreactor Design, Scaffolds System and Bioprocessing
Session 405: Synthetic Materials-Biomaterials and Scaffolds
Session 406: Micro and Nanotechnologies in Engineering Stem Cells and Tissues
Session 407: ECM Biology, Functions, and Cell-ECM Interaction in Tissue Engineering
Session 401: Biomechanics Stem Cell and Tissue
Session 402: Computer-Aided Tissue Engineering
Session 403: Biofabrication and Tissue Engineering
Session 404: Cell Culture, Bioreactor Design, Scaffolds System and Bioprocessing
Session 405: Synthetic Materials-Biomaterials and Scaffolds
Session 406: Micro and Nanotechnologies in Engineering Stem Cells and Tissues
Session 407: ECM Biology, Functions, and Cell-ECM Interaction in Tissue Engineering
Stream 3: Workshop for Best Industrial Practice Symposia
Module 6: Stem Cell Products Regenerative Medicine Funding and Investment
Stream 4: Business & Social Events
Event 1: Match Making, Career Fair, and Partnership
Event 2: Business Development Roundtable and New Product Briefing
Event 3: Posters and Exposition
Event 4: Welcome Banquet
Event 5: Field Trip to Stem Cell Corporation
Event 6: Korea Impression Tech-Tour
Event 2: Business Development Roundtable and New Product Briefing
Event 3: Posters and Exposition
Event 4: Welcome Banquet
Event 5: Field Trip to Stem Cell Corporation
Event 6: Korea Impression Tech-Tour
著名演講人：
Dr. Stephen Minger, Chief Scientist, Cellular Sciences, GE Healthcare Life Sciences, UK
Dr. Robert Deans, Executive Vice President, Regenerative Medicine, Athersys, Inc, USA
Dr. Mariusz Z. Ratajczak, Editor-in-Chief, the Central European Journal of Biology; Professor, James Graham Brown Cancer Center, University of Louisville, USA
Dr. Gilson Khang, TERMIS-AP Continental Chair-Elect; Co-Editor-in-Chief, International Journal of Tissue Regenerations; Professor, Chonbuk National University, South Korea
Dr. Gilson Khang, TERMIS-AP Continental Chair-Elect; Co-Editor-in-Chief, International Journal of Tissue Regenerations; Professor, Chonbuk National University, South Korea
Dr. Anton C. Krucky, President & CEO, Tissue Genesis, Inc., USA
Dr. Johan Hyllner, Chief Scientific Officer, Cell Therapy Catapult, UK
Dr. Wojtek Auerbach, Senior Director, Regeneron Pharmaceuticals, USA
Dr. Rahul Aras, President, Juventas Therapeutics, USA
Dr. Fritz Lahrtz, Patentanwalt / European Patent Attorney, Isenbruck Bösl Hörschler LLP, Germany
Dr. Johan Hyllner, Chief Scientific Officer, Cell Therapy Catapult, UK
Dr. Wojtek Auerbach, Senior Director, Regeneron Pharmaceuticals, USA
Dr. Rahul Aras, President, Juventas Therapeutics, USA
Dr. Fritz Lahrtz, Patentanwalt / European Patent Attorney, Isenbruck Bösl Hörschler LLP, Germany
Dr. Anthony E. Ting, Senior Director, Regenerative Medicine, Head, Cardiovascular and Pulmonary R&D, Athersys, Inc., USA
Dr. Nabil Hagag, Professor, State University of New York At Stony Brook, USA
Dr. Nabil Hagag, Professor, State University of New York At Stony Brook, USA
Dr. Laura Riboni, Professor, University of Milan, Italy
Dr. Alexander Kharazi, Chief Technology Officer, Stemedica Cell Technologies, Inc., USA
Dr. Anand Gadre, Director, Stem Cell Instrumentation Foundry, University of California, USA
Dr. Anand Gadre, Director, Stem Cell Instrumentation Foundry, University of California, USA
Dr. Ralf Huss, Chief Scientific Officer, apceth GmbH & Co. KG, Germany
Dr. Ross Macdonald, Managing Director and Chief Executive Officer, Cynata Therapeutics Ltd, Australia
Dr. Senyon Choe, Professor, Joint Center for biosciences & Salk Institute, USA
Dr. Julie Anderson, Professor, Buck Institute for Age Research, USA
Dr. Senyon Choe, Professor, Joint Center for biosciences & Salk Institute, USA
Dr. Julie Anderson, Professor, Buck Institute for Age Research, USA
Dr. Edda Tobiasch, Professor, Department of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Germany
Dr. Anand S. Srivastava, Chairman and Co-founder, Global Institute of Stem Cell Therapy and Research, USA
Dr. Anand S. Srivastava, Chairman and Co-founder, Global Institute of Stem Cell Therapy and Research, USA
Dr. John Yu, Professor and Director, Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital, Chang Gung University; Founder, Taiwan Society for Stem Cell Research, Taiwan
Dr. Alain Vertes, Managing Director, NxR Biotechnologies, Switzerland; Sloan Fellow, London Business School, UK
Dr. Alain Vertes, Managing Director, NxR Biotechnologies, Switzerland; Sloan Fellow, London Business School, UK
Dr. Jose R. Nunez, Professor, WHO, Switzerland
Dr. Young-Ho Lee, Chairman, Department of Pediatrics, Hanyang University Medical Center, South Korea
Dr. Kwang-Sup Soh, Professor, Seoul National University, South Korea
Dr. Sang-Suk Lee, Professor & Dean, College of Health and Science, Sangji University, Wonju, South Korea
Dr. Sang-Suk Lee, Professor & Dean, College of Health and Science, Sangji University, Wonju, South Korea
Dr. Yang-Sook Chun, Professor, Epigenomics & Microenvironment Remodeling Laboratory, Seoul National University College of Medicine, South Korea
韓國(guó)旅游
釜山是韓國(guó)第二大城市，擁有人口360萬(wàn)，是韓國(guó)最大港口城市也是世界最繁忙的海港之一。釜山位于朝鮮半島東南端的海岸上，北面、西面靠著低山，南面、東面臨海，其氣候溫和舒適，很少有過(guò)熱或過(guò)冷的天氣，是一個(gè)風(fēng)景旖旎秀麗的海濱城市。無(wú)論是其山川景色還是海洋風(fēng)光都是理想的觀光之地。其主要的旅游名勝有寺廟，各種殿閣等，療養(yǎng)勝地有大的海水浴場(chǎng)、島嶼和海岸公園多處，其中近海的影島是游人不可不去的風(fēng)光區(qū)。每年3月。釜山會(huì)舉辦國(guó)際表演藝術(shù)節(jié)。釜山是個(gè)國(guó)際會(huì)議中心，是2002年亞運(yùn)會(huì)和2005年APEC的承辦城市，已經(jīng)發(fā)展為多種文化共存的國(guó)際性現(xiàn)代大都市。旅游線路：http://www.bitcongress.com/RMSC-Korea2015/cn/TechTour.asp
參會(huì)價(jià)格
A套票 (含4星級(jí)酒店住宿)
|
2014年11月25日之前 |
2014年12月25日之前 |
2015年1月25日之前 |
2015年3月19日之前 | ||||
|
學(xué)術(shù) |
企業(yè) |
學(xué)術(shù) |
企業(yè) |
學(xué)術(shù) |
企業(yè) |
學(xué)術(shù) |
企業(yè) |
|
$1999 |
$2099 |
$2099 |
$2199 |
$2199 |
$2299 |
$2499 |
$2599 |
A套票包含項(xiàng)目:
1). 可參加所有論壇、在某一專場(chǎng)發(fā)表演講，時(shí)間為25分鐘
2). 會(huì)議期間1人午餐(3月19-21日)
3). 會(huì)議期間1人晚餐(3月18、20、21日)
4). 歡迎晚宴 (3月19日)
5). 會(huì)議期間4星級(jí)酒店住宿4晚，含單早 (3月18日-3月21日)
6). 會(huì)議資料1份
7). 投遞會(huì)議英文摘要1篇或展板1塊（需要請(qǐng)?zhí)崆奥?lián)系會(huì)務(wù)組）
8). 會(huì)議期間往返于酒店與會(huì)場(chǎng)之間班車
9) 會(huì)議期間茶歇
|
2014年11月25日之前 |
2014年11月25日之前 |
2015年1月25日之前 |
2015年3月19日之前 | ||||
|
學(xué)術(shù) |
企業(yè) |
學(xué)術(shù) |
企業(yè) |
學(xué)術(shù) |
企業(yè) |
學(xué)術(shù) |
企業(yè) |
|
$899 |
$999 |
$999 |
$1099 |
$1099 |
$1199 |
$1399 |
$1499 |
注冊(cè)費(fèi)包含項(xiàng)目:
1). 可參加所有論壇、在某一專場(chǎng)發(fā)表演講，時(shí)間為25分鐘
2). 會(huì)議期間1人午餐(3月19-21日)
3). 會(huì)議期間茶歇
4). 歡迎晚宴 (3月19日)
5). 會(huì)議資料1份
6). 投遞會(huì)議英文摘要1篇或展板1塊（需要請(qǐng)?zhí)崆奥?lián)系會(huì)務(wù)組）
|
項(xiàng)目 |
2014年11月25日之前 |
2014年12月25日之前 |
2015年1月25日之前 | ||||
|
學(xué)術(shù) |
企業(yè) |
學(xué)術(shù) |
企業(yè) |
學(xué)術(shù) |
企業(yè) | ||
|
學(xué)術(shù)展板 |
$220 |
$240 |
$220 |
$240 |
$220 |
$240 | |
|
會(huì)刊廣告 ( 140mm * 210mm , 彩頁(yè)) |
彩色內(nèi)頁(yè) |
$700 |
$800 |
$800 |
$900 |
- |
- |
|
扉頁(yè) |
$1300 |
$1400 |
$1400 |
$1500 |
- |
- | |
|
內(nèi)封 |
$1300 |
$1400 |
$1400 |
$1500 |
- |
- | |
|
封底 |
$1400 |
$1500 |
$1500 |
$1600 |
- |
- | |
|
海報(bào)楣板廣告 ( 1200mm * 2000mm ) |
$1300 |
$1400 |
$1400 |
$1500 |
$1700 |
$1800 | |
|
手袋廣告 ( 500mm * 350mm ) |
$3800 /100bags |
$3800 /100bags |
$4000 /100bags |
$4000 /100bags |
- |
- | |
參展價(jià)格
|
票類 |
2014年11月25日之前 |
2014年11月25日之前 |
2015年1月25日之前 |
|
參展A票 |
$1,899 |
$1,999 |
$2,099 |
|
參展B票 |
$2,399 |
$2,499 |
$2,599 |
|
參展C票 |
$2,799 |
$2,899 |
$2,999 |
A票：
1. 9㎡ 標(biāo)準(zhǔn)展位1個(gè), 咨詢桌1張, 椅子2把, 電源插座1個(gè),射燈2盞
2. 展商logo放在會(huì)議網(wǎng)站展商列表處
3. 展商logo放在會(huì)刊展商名單處
4. 在會(huì)刊中放置200個(gè)字的展商介紹1篇
5. 會(huì)議資料1份
6. 參會(huì)票1張（可參加所有論壇）
7. 歡迎晚宴券1張
8. 會(huì)議期間午餐券1套
9. 會(huì)前1個(gè)月提供參會(huì)人員名單
10. 會(huì)后提供參會(huì)人員通訊錄
B票
1. 9㎡ 標(biāo)準(zhǔn)展位1個(gè), 咨詢桌1張, 椅子2把, 電源插座1個(gè),射燈2盞
2. 展商logo放在會(huì)議網(wǎng)站展商列表處
3. 展商logo放在會(huì)刊展商名單處
4. 在會(huì)刊中放置200個(gè)字的展商介紹1篇
5. 會(huì)議資料1份
6. 歡迎晚宴券1張
7. 會(huì)議期間午餐券2套
8. 四星級(jí)酒店住宿4晚
9. 會(huì)前1個(gè)月提供參會(huì)人員名單
10. 會(huì)后提供參會(huì)人員通訊錄
C票
1. 9㎡ 標(biāo)準(zhǔn)展位1個(gè), 咨詢桌1張, 椅子2把, 電源插座1個(gè),射燈2盞
2. 展商logo放在會(huì)議網(wǎng)站展商列表處
3. 展商logo放在會(huì)刊展商名單處
4. 在會(huì)刊中放置200個(gè)字的展商介紹1篇
5. 會(huì)議資料1份
6. 歡迎晚宴券2張
7. 四星級(jí)酒店住宿4晚
8. 可在會(huì)議某一專場(chǎng)做報(bào)告，時(shí)間為25分鐘
9. 會(huì)前1個(gè)月提供參會(huì)人員名單
10. 會(huì)后提供參會(huì)人員通訊錄
注意：
（1）所有代表請(qǐng)務(wù)必到網(wǎng)上注冊(cè)，并留取E-mail，因?yàn)闀?huì)務(wù)組將在會(huì)前會(huì)后通過(guò)E-mail發(fā)送會(huì)議進(jìn)展、會(huì)議指南、會(huì)議通知及會(huì)后照片、通訊錄等信息。
（2）取消注冊(cè)，必須在2015年2月10日之前，通過(guò)郵件vicki@的形式通知會(huì)務(wù)組，退還50％的注冊(cè)費(fèi)。超過(guò)此截止期，不退還費(fèi)用。
（3）請(qǐng)參會(huì)者在會(huì)場(chǎng)注冊(cè)臺(tái)報(bào)到時(shí)出示匯款底單原件或復(fù)印件。
（4）此價(jià)格只針對(duì)常駐中華人民共和國(guó)大陸常住居民。包括持有中國(guó)公民身份的外籍人士。
（2）取消注冊(cè)，必須在2015年2月10日之前，通過(guò)郵件vicki@的形式通知會(huì)務(wù)組，退還50％的注冊(cè)費(fèi)。超過(guò)此截止期，不退還費(fèi)用。
（3）請(qǐng)參會(huì)者在會(huì)場(chǎng)注冊(cè)臺(tái)報(bào)到時(shí)出示匯款底單原件或復(fù)印件。
（4）此價(jià)格只針對(duì)常駐中華人民共和國(guó)大陸常住居民。包括持有中國(guó)公民身份的外籍人士。
付款方式：
以下銀行賬號(hào)接受人民幣匯款，請(qǐng)中國(guó)的參會(huì)人員提前與會(huì)務(wù)組協(xié)調(diào)員聯(lián)系，根據(jù)當(dāng)前美元兌人民幣匯率進(jìn)行換算，確定人民幣金額后再匯款：
銀行電匯會(huì)務(wù)費(fèi)指定賬戶：
戶 名：百奧泰國(guó)際會(huì)議(大連)有限公司
開(kāi)戶行：中國(guó)銀行大連高新園區(qū)支行
帳 號(hào)： 3168 5632 6333
注意：請(qǐng)?jiān)趨R款單上務(wù)必標(biāo)明“2015第八屆再生醫(yī)學(xué)和干細(xì)胞大會(huì)”字樣，并將匯款單掃描回傳至?xí)⻊?wù)組以便確認(rèn)，回傳單上請(qǐng)注明匯款人姓名及所需開(kāi)具發(fā)票的名頭、快遞收件人信息。郵箱：vicki@
2015第八屆再生醫(yī)學(xué)與干細(xì)胞大會(huì)會(huì)務(wù)組
聯(lián)系人：Vicki Qian
電話：0411-84799609-801；18504200209
Q Q: 1950231799(請(qǐng)注明咨詢會(huì)議)
電子郵件：vicki@
地址：大連市高新園區(qū)匯賢園1號(hào) 郵編：116025
- 2025第25屆合肥食品安全檢測(cè)技術(shù)高峰論壇通知
- 進(jìn)科馳安攜流式分選儀等參加全國(guó)細(xì)胞外囊泡大會(huì)
- 第7屆北京國(guó)際醫(yī)療器械及醫(yī)院建設(shè)展火熱招商中
- CPHI&PMEC 2025世界制藥原料中國(guó)展預(yù)登記已開(kāi)啟
- 第十七屆ChinaBio®生物醫(yī)藥產(chǎn)業(yè)國(guó)際合作大會(huì)通知
- 2025北京檢驗(yàn)醫(yī)療與體外診斷及耗材展火熱招商中
- 霍爾斯參加2024未來(lái)微藻生物制造創(chuàng)新研討會(huì)
- 2024年I2SL國(guó)際可持續(xù)發(fā)展實(shí)驗(yàn)室會(huì)議成功舉辦
- 澤權(quán)儀器精彩亮相2024科學(xué)家創(chuàng)新大會(huì)
- 第十三屆生物質(zhì)能源與有機(jī)固廢資源化利用論壇通知
- 第四屆三亞國(guó)際種業(yè)科學(xué)家大會(huì)日程表&嘉賓名單
- 2025合成生物概念驗(yàn)證平臺(tái)技術(shù)與智能裝備論壇通知
- FFC 2025功能性食品大會(huì)通知
- 博普特種質(zhì)資源產(chǎn)品將參展第四屆三亞種業(yè)科學(xué)家大會(huì)
- 2025 細(xì)胞產(chǎn)業(yè)大會(huì)（上海）通知
- 安捷倫SureSelect Max文庫(kù)制備方案上市，免費(fèi)試用
- 10x Genomics GEM-X質(zhì)量挑戰(zhàn)大賽獲獎(jiǎng)名單公布
- 2025第十三屆國(guó)際基因節(jié)通知
- 因美納攜手復(fù)旦大學(xué)開(kāi)展職業(yè)能力工作坊，匯聚新生力
- 10x講座：?jiǎn)渭?xì)胞與空間組學(xué)推動(dòng)植物研究前沿突破
- 森西賽智參加分子腫瘤學(xué)全國(guó)重點(diǎn)實(shí)驗(yàn)室2024學(xué)術(shù)年會(huì)
- 浙大、真邁等聯(lián)合申報(bào)的科技創(chuàng)新2030重大項(xiàng)目獲批
- 講座：用單細(xì)胞與空間技術(shù)推動(dòng)植物研究的全新突破
- 10x發(fā)布GEM-X Flex解決方案助力百萬(wàn)單細(xì)胞測(cè)序
- 10x線上研討會(huì)：您的FFPE樣本時(shí)空多組學(xué)了嗎？
- 10x Genomics技術(shù)方案更新(10月)，新指南等您獲取
- 第四屆多組學(xué)科研與臨床應(yīng)用大會(huì)通知
- 更簡(jiǎn)便快速，因美納發(fā)布MiSeq i100系列桌面式測(cè)序儀
- 森西賽智科技受邀參加第六屆全國(guó)病毒腫瘤學(xué)學(xué)術(shù)大會(huì)
Copyright(C) 1998-2024 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com